高效液相色谱法测定人血中普鲁卡因酰胺及其代谢产物N-乙酰普鲁卡因酰胺
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINATION OF PROCAINAMIDE AND ITS ACTIVE METABOLITES, N-ACETYLPROCAINAMIDE IN SERUM
-
摘要: 本文用高效液相色谱法测定人血中普鲁卡因酰胺(PA)及其代谢产物N-乙酰普鲁卡因酰胺(NAPA)。以正丙醇—氯仿(1:9)提取血清样品,蒸干,残渣用流动相溶解;色谱分析条件:NOVA-PAK 5μm ODS柱,醋酸(40 ml)—醋酸钠(4g)—水(1000ml)—乙腈(100ml)为流动相;定量分析以普鲁卡因为内标,样品的比率色谱图表明分离良好,PA和NAPA的线性测定范围分别为0.5~12.0μg/ml和0.5~6.0μg/ml,相关系数均优于0.99,平均回收率分别为99.4%和100.5%,平均变异系数分别为4.16%和4.36%。方法适用于血清样品分析和治疗药物监测,对病人血样的测定结果表明方法不受干扰。Abstract: A rapid HPLC procedure has been developed for the determination of procainamide (PA) and N-acetyl procainamide (NAPA) in serum. PA and NAPA were extracted from human serum by using a mixture of n-propanol and chloroform(1:9). The organic phase was evaporated to dryness under a gentle stream of dry nitrogen at 40~50℃. The residue was redissolved in 200 μl mobile phase containing procaine internal standard and 20μl samples were analysed on a column (3.9 mm × 15 cm) of, NOVA-PAK C 18 (51μm) by using the mobile phase (1ml/min) of acetic acid (40ml)-sodium acetate (4g)-H2O (1000ml)-acetonitrile (100ml) and detecting at 254nm. The calibration plot was rectilinear over the range 0.5~121μg/mlof PA, and 0.5~0.6μg/ml of NAPA. The average recovery of PA and NAPA was 99.4% and 100.5%, while the average CV was 4.16% and 4.13%, respectively. The method was found to be adequate for monitoring the human serum concentration vs. time profile of PA and NAPA after oral administration of PA and for determining acetylator phenotype based on a ratio of NAPA to PA in serum.
下载: